Skip to content

Clinical study on the analgesic effect of HuLisan after total knee arthroplasty

Clinical study on the analgesic effect of HuLisan after total knee arthroplasty

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081975
Enrollment
Unknown
Registered
2024-03-18
Start date
2024-03-18
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of knee joint

Interventions

experimental group :On the basis of conventional analgesic regimen, take tiger li powder tablets (1 tablet / time, 2 times / day after 6h postoperative fasting period).
control group
matched group :Treatment according to the routine analgesic regimen.

Sponsors

Xi'an Honghui hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) According to the surgical indications, the diagnosis result of knee osteoarthritis by clinical and imaging examination is knee osteoarthritis (2) The subjects of the study were adult patients who planned to undergo primary unilateral total knee arthroplasty (3) The age is 50-80 years old (4) The American Society of Anesthesiology (ASA) evaluates the grade as 1-2 (5) No contraindications (6) The patient agrees to sign the informed consent form

Exclusion criteria

Exclusion criteria: (1) Patients with a history of unhealthy liver and kidneys, severe cardiopulmonary disease, severe digestive tract disease, and mental illness (2) Patients who are allergic to Hulisan or substances (3) Patients taking Huli Powder Tablets or opioids within 2 weeks before surgery (4) Patients with mental illness and cognition

Design outcomes

Primary

MeasureTime frame
Pain score;

Secondary

MeasureTime frame
Range of motion of the knee joint;Consumption of the opioids;blood examination ;

Countries

China

Contacts

Public ContactHuangYuanchi

Xi'an Honghui hospital

huangychell@163.com+86 180 9297 0326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026